Basic Formulation Semblance and Contemporary Approach of Mini Tablets
DOI:
https://doi.org/10.37285/ijpsn.2023.16.1.6Abstract
As a new approach to solid dosage forms, mini-tablets (MTs) are designed to subjugate some kind of therapeutic disincentives, like poor swallowing properties and polypharmacy therapy, as well as to provide therapeutic advantages like dose flexibility and release patterns. These pills are a viable method of delivering medication to patients. It has smaller tablets than typical, with a diameter of between 2 and 3 mm, compared to conventional tablets. Other advantages of tiny tablets include their uniform shape and size, which reduces unit-to-unit fluctuation in the medicine and allows for precise weighing of the substance. Since they have a very smooth surface area, it is possible to cover them with a drug-delaying coating in order to prolong their shelf life. It can also be used in the same way as other multiple-dose forms, such as capsules. MTs are a good substitute for pellets and granules. Lower potential drugs can be encapsulated as mini tablets in different sizes of gelatin capsule shells if the qualities are adequately regulated. This review article depicts various aspects of mini-tablets, such as their marketed product, types, formulation prospects, current trends of manufacturing, novelties in research work, and patent-related works that will be beneficial for those who are conducting research on the formulation and development of this mini tablet dosage form.
Downloads
Metrics
Keywords:
Encapsulatio, gastro retentive, mini tablets, pulsatile, oral drug delivery, pediatrics
Downloads
Published
How to Cite
Issue
Section
References
Mitra B, Chang J, Wu SJ, Wolfe CN, Ternik RL. Feasibility of mini-tablets as a flexible drug delivery tool. Int J Pharm 2017; 52(5):149-159.
Goh HP, Heng PWS, Liew CV. Understanding die fill variation during mini-tablet production. Int J Pharm 2017; 53(4): 279-286.
Opeyemi OT, Adegbenro OO. Development and characterization of direct compressed matrix mini tablets of naproxen sodium. Univers J Pharm Res 2018; 3(5): 7-11.
Freerks L, Sommerfeldt P, Loper PC, Klein S. Swallowable and palatable paediatric mini tablet formulations for a WHO model list of essential medicines for children compound. A promising starting point for future PUMA applications. Eur J of Pharm and Biopharm 2020; 15(6): 11-19.
Ard L, Guillaume T, Peter K, Jorg B. Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions. Int J Pharm 2020;100061.
Münch J, Meissner T, Mayatepek E, Wargenau M, Breitkreutz J, Bosse HM, Klingmann V, et al. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial. Eur J of Pharm and Biopharm 2021; 16(6): 126-134.
Klingmann V, Linderskamp H, Meissner T, Mayatepek E, Moeltner A, Breitkreutz J, Bosse HM, et al. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial. The J Pediatr 2018; (20)1: 202-207.
Ilhan E, Ugurlu T, Kerimoglu O. Mini Tablets: A Short Review-Revision. Peertechz J Med Chem Res 2017; 3(1): 12-22.
Shah BA, Patel AS, Patel BJ, Patel DJ, Qu A. Mini-Tablet Drug Delivery System for Pediatric Dosage Form (PDF): A Review of Manufacturing Perspectives. Int J Drug Deliv Res 2018; 10(1): 47-52.
Shah N, Mehta T, Aware R, Shetty V. Investigation on influence of Wurster coating process parameters for development of delayed release mini tablets of Naproxen. Drug Dev Ind Pharm 2017; 43(12): 1989-1998.
Madathilethu J, Roberts M, Peak M. Content uniformity of quartered hydrocortisone tablets in comparison with mini-tablets for paediatric dosing. BMJ Paediatr Open 2017; 2(1): 01-07.
Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG, et al. Minitablets: New modality to deliver medicines to preschool-aged children. Pediatrics 2009; 123(2): 235-238.
Lura A, Tardy G, Kleinebudde P, Breitkreutz J. Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions. Int J Pharm X 2020; 2: 100061: 01-13.
Kurashima H, Uchida S, Kashiwagura Y, Tanaka S, Namiki N. Evaluation of Weight Variation in Mini-Tablets Manufactured by a Multiple-Tip Tool. Chem Pharm Bull (Tokyo) 2020; 68(10): 981-988.
Moosa RM, Choonara YE, du Toit LC, Kumar P, Carmichael T, Tomar LK, Tyagi C, Pillay V. A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye. J Pharm Pharmacol 2014; 66(4): 490-506.
Mitra B, Chang J, Wu SJ, Wolfe CN, Ternik RL, Gunter TZ, Victor MC, et.al. Feasibility of mini-tablets as a flexible drug delivery tool. Int J Pharm 2017; 525(1): 149-159.
Mitra B, Thool P, Meruva S, Aycinena JA, Li J, Patel J, Patel K, Agarwal A, Karki S, Bowen W. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing. Int J Pharm 2020; 574: 118905.
Tawfeek HM, Roberts M, El Hamd MA, Abdellatif AAH, Younis MA. Glibenclamide Mini-tablets with an Enhanced Pharmacokinetic and Pharmacodynamic Performance. AAPS J 2018; 19(7): 2948-2960.
Hiorth M, Nilsen S, Tho I. Bioadhesive mini-tablets for vaginal drug delivery. Pharmaceutics 2014; 6(3):494-511.
Krause J, Müller L, Sarwinska D, Seidlitz A, Sznitowska M, Weitschies W. 3D Printing of Mini Tablets for Pediatric Use. Pharmaceuticals (Basel) 2021; 14(2): 143-153.
Turk M, Šibanc R, Dreu R, Frankiewicz M, Sznitowska M. Assessment of Mini-Tablets Coating Uniformity as a Function of Fluid Bed Coater Inlet Conditions. Pharmaceutics 2021; 13(5):746-756.
Lazzari A, Kleinebudde P, Knop K. Xanthan gum as a rate-controlling polymer for the development of alcohol resistant matrix tablets and mini-tablets. Int J Pharm 2018; 536(1):440-449.
Soulairol I, Chaheen M, Tarlier N, Aubert A, Bataille B, Sharkawi T, et al. Evaluation of disintegrants functionality for orodispersible mini tablets. Drug Dev Ind Pharm 2017; 43(11):1770-1779.
Richey RH, Hughes C, Craig JV. A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice. Int J Pharm 2017; 518(1-2):155–166.
Mohamed FA, Roberts M, Seton L, Ford JL, Levina M. Film-coated matrix mini-tablets for the extended release of a water-soluble drug. Drug Dev Ind Pharm 2015; 41(4):623-630.
Tehseen N, Rao V, Hadi MA. Design and Characterization of Twice Daily Mini-tablets Formulation of Pregabalin. Int J Pharm Pharm Sci 2013; 5(1):168-175.
Sagar Kumar R, Kulkarni M.P, Vandana P.B, Wadhwa S., Singh G, Sharma A, et al. Minitablets: Recent Trends and Developments with an update on Research and Patents, BFAIJ 2021; 13(2):01-09.
Priyanka J, Kapil Kumar, Deepak Teotia, A comprehensive review on pharmaceutical mini tablets, J Drug Deliv Ther 2018; 8(6):382-390.
Nweje-Anyalowu Paul C, Anyalogbu Ernest AA, White Alalibo Jim. Design and evaluation of chrono therapeutic pulsatile drug delivery system of Cilnidipine. Univers J Pharm Res 2017; 2(5):18-22.
Alfred CFR, David H, Francis F, Varsha B, Mary AJ. Minitablets: Manufacturing, Characterization Methods, and Future Opportunities. Am Pharm Rev 2016.
Thabet Y, Walsh J, Breitkreutz J. Flexible and Precise Dosing of Enalapril Maleate for All Paediatric Age Groups Utilizing Orodispersible Minitablets. Int J Pharm 2018; 541, 136-142.
H. Mohd Abdul, NG Raghavendra, A Srinivasa Rao. Formulation and Evaluation of pH-Responsive Mini-Tablets for Ileo-Colonic Targeted Drug Delivery. Trop J Pharm Res 2014; 13(7):1021-1029.
Hadi MA, Rao R, Rao NG. Formulation and Evaluation of pH-Responsive Mini-Tablets for Ileo-Colonic Targeted Drug Delivery. Trop J Pharm Res 2014; 13(7):1021-1029.
Kishore M, Vijaya Kumar B, Narsimha Reddy Y. Formulation and evaluaion of pH-responsive mini-tablets for atenolol colonic drug delivery system. Int J Pharm Bio Sci 2015; 5(1):05-10
Klingmann V, Seitz A, Meissner T, Breitkreutz J, Moeltner A, Bosse H.M, et al. Acceptability of Uncoated Mini-Tablets in Neonates—A Randomized Controlled Trial. The J Paediatrics 2015; 167,893–896.
Hayakawa Y, Uchida S, Namiki N. Evaluation of the ease of taking mini-tablets compared with other tablet formulations in healthy volunteers. Eur J of Pharm Sci 2016; 84:157-161.
Aleksovski A, Dreu R, Gašperlin M, Planinšek O. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert Opin Drug Deliv 2015; 12(1):65-84.
K. M. El-Say, Tarek A Ahmed, Maged F Abdelbary, Bahaa E Ali, Bader M Aljaeid, Ahmed S Zidan, et al. Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics, Acta Pharm 2015; 65(4):365–382.
Bayan MF, Saadh M, Sbaih H. Mini-Tablets Overview. Int J Pharm Res Technol 2021; 11(1):44-55.
Vikas J, Sarashetti S, Pooja M, Satish B. Recent developments in orally disintegrating mini tablets. Int J Res Pharma Sci 2020; 11(3),3606-3612.
Zuccari G, Alfei S, Marimpietri D, Iurilli V, Barabino P, Marchitto L. Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics. Pharmaceuticals 2022; 15(1):108.
Mina M, Badawy A, Demiana I, Nevine S, Elmalak A. Drotaverine hydrochloride gastroretentive floating mini-tablets: Formulation, in-vitro and in-vivo evaluation. J Drug Deliv Sci Technol 2020; 57:1017-1033.
Ortega A, Claudia , Favier S. Laura , Cianchino A. Valeria, Cifuente A, et al. Diego. New Orodispersible Mini Tablets of Enalapril Maleate by Direct Compression for Pediatric Patients. Curr Drug Deliv 2020; 17(6).
Noppawan C, Phaechamud T, Ritthidej G. Development of Prolonged Action, Bioadhesive and Slowly Dissolving Minitablets. Adv Mat Res 2010; 93-94: 425-428.
Ahmed B, Ibrahim H, Haza B, Ibrahim S. Formulation of sustained release bioadhesive minitablets containing solid dispersion of levofloxacin for once daily ocular use. Pharma Dev Tech 2019; 24(7):824-838.
Shah B, Patel A, Patel B, Patel D, Anthony Q. Mini-Tablet Drug Delivery System for Pediatric Dosage Form (PDF): A Review of Manufacturing Perspectives. Int J Drug Dev Res 2018; 10:47-52.
Aleksovski A, Dreu R, Gasperlin M, Planinsek O. Mini-tablets: A contemporary system for oral drug delivery in targeted patient groups. Exp Opin Drug Deliv 2015; 12(1): 65-84.
Kishore M, Vijaya Kumar B, Narsimha Reddy Y. Formulation and Evaluaion of pH-Responsive Mini-Tablets for Atenolol Colonic Drug Delivery System. Int J Pharm Biol Sci 2015; 5(1):05-10.
Sateesh Kumar V. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets. AAPS 2015; 16(6):1465–1473.
Hauptstein S, Müller C, Dünnhaupt S, Laffleur F, Bernkop-Schnürch A. Preactivated thiomers: evaluation of gastroretentive minitablets. Int J Pharm 2013; 456(2):473-479.
Wasilewska K, Ciosek-Skibińska P, Lenik J, Srčič S, Basa A, Winnicka K. Utilization of Ethylcellulose Microparticles with Rupatadine Fumarate in Designing Orodispersible Minitablets with Taste Masking Effect. Materials (Basel) 2020; 13(12):2715.
Patil.H, Tiwari RV, Repka MA. Hot-Melt Extrusion: from Theory to application in Pharmaceutical Formulation. AAPS Pharm Sci Tech 2016; 20-42.
Sergio Arroyo Hidalgo, José Miguel Rizo Martinez, Teresa Castilla. Pharmaceutical mini-tablets for sustained release of flecainide acetate. European Patent Application No. EP10382031A, 12 February 2010.
Neurim Pharmaceuticals Ltd. (Tel Aviv, Israel). Melatonin Mini Tablets and method of manufacturing. US Patent Application No. 10,869,857, 16 June 2020.
Gabriel Marinus Henricus Meesters, Ferdinand Antoine Spros. Mini Tablets. US Patent Application No. 14/420, 966, 11 February 2015.
Siva Rama Krishna Nutalapati, Rakeshkumar Khushalbhai Lad. Multilayer Mini Tablets with different release rates. US Patent Application No. 13/165, 893, 22 June 2011.
Maurice Joseph Anthony Clancy, Kenneth Iain Cumming. Cisapride MiniTablet Formulations. US Patent Application No. 08/995, 583, 29 June 2000.
Isabelle Rault. Bioadhesive mini tablets. US Patent Application No. 09/063, 361, 21 April 1998.
Türkyilmaz Ali, Zenginer Sibel, Yag Göksu. Paliperidone Mini Tablets. European Patent Application No. 16207100.5, 05 July 2017.
Poller B, Strachan C, Broadbent R, Walker GF. Minitablet Formulation Made from Electrospun Nanofibers. Eur J of Pharm and Biopharm 2017; 114:213-220.
Alshetaili AS, Almutairy BK, Tiwari RV, Morott JT, Alshehri SM, Feng X, Alsulays BB, Park JB, Zhang F, Repka MA, et al. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets. Curr Drug Deliv 2016; 13(5):730-741.
Rycerz K, Stepien KA, Czapiewska M, Arafat BT, Habashy R, Isreb. A, Peak M, Alhnan MA. Embedded 3D Printing of Novel Bespoke Soft Dosage Form Concept for Pediatrics. Pharmaceutics 2019; 11:630.
Ayyoubi S, Cerda JR, Fernández-García R, Knief P, Lalatsa A, Healy AM, Serrano DR et al. 3D Printed Spherical Mini-Tablets: Geometry versus Composition Effects in Controlling Dissolution from Personalised Solid Dosage Forms. Int J Pharm 2021; 597:120336.
Gupta S, Thool P, Meruva S, Li J, Patel J, Agrawal A, Karki S, Bowen W, Mitra B, et al. Development of Low Dose Micro-Tablets by High Shear Wet Granulation Process. Int J Pharm 2020; 587:119571.
Chen H, Wang C, Liu S, Sun CC. Development of Piroxicam Mini-Tablets Enabled by Spherical Cocrystallization. Int J Pharm 2020; 590:119953.
Meruva S, Thool P, Gong Y, Agrawal A, Karki S, Bowen W, Mitra B, Kumar S, et al. A Novel Use of Nanocrystalline Suspensions to Develop Sub-Microgram Dose Micro-Tablets. J Pharm Sci 2021; 110:3276-3288.
Hagen E, Løding FS, Mattsson S, Tho I. Use of Interactive Mixtures to Obtain Mini-Tablets with High Dose Homogeneity for Paediatric Drug Delivery. J Drug Deliv Sci Technol 2016; 34: 51-59.
